MAP2K7 and breast cancer: In a previous study, α-TOS demonstrated strong cell cycle arrest at the S-phase in MDA-MB-453 breast cancer cells following MEK and ERK kinase inhibition and the upregulation of the tumor suppressive protein P21 [39].